The potential role of inhibitor of differentiation-3 in human adipose tissue remodeling and metabolic health

Despres, 2008, Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk, Arterioscler. Thromb. Vasc. Biol., 28, 1039, 10.1161/ATVBAHA.107.159228 Calle, 2004, Obesity and cancer, Oncogene, 23, 6365, 10.1038/sj.onc.1207751 Ross, 2002, Abdominal adiposity and insulin resistance in obese men, Am. J. Physiol. Endocrinol. Metab., 282, E657, 10.1152/ajpendo.00469.2001 Lapidus, 1984, Distribution of adipose tissue and risk of cardiovascular disease and death: a 12year follow up of participants in the population study of women in Gothenburg, Swed. Br. Med. J., 289, 1257, 10.1136/bmj.289.6454.1257 Bergman, 2006, Why visceral fat is bad: mechanisms of the metabolic syndrome, Obesity, 14, 16S, 10.1038/oby.2006.277 Pouliot, 1992, Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels, Diabetes, 41, 826, 10.2337/diab.41.7.826 Christy, 1991, An Id-related helix–loop–helix protein encoded by a growth factor-inducible gene, Proc. Natl. Acad. Sci. U. S. A., 88, 1815, 10.1073/pnas.88.5.1815 Jones, 2004, An overview of the basic helix–loop–helix proteins, Genome Biol., 5, 226, 10.1186/gb-2004-5-6-226 Kumar, 2003, Smooth muscle alpha-actin gene requires two E-boxes for proper expression in vivo and is a target of class I basic helix–loop–helix proteins, Circ. Res., 92, 840, 10.1161/01.RES.0000069031.55281.7C Massari, 2000, Helix–loop–helix proteins: regulators of transcription in eucaryotic organisms, Mol. Cell. Biol., 20, 429, 10.1128/MCB.20.2.429-440.2000 Atherton, 1996, Regulation of cell differentiation in C2C12 myoblasts by the Id3 helix–loop–helix protein, Cell Growth Differ., 7, 1059 Jen, 1997, Each member of the Id gene family exhibits a unique expression pattern in mouse gastrulation and neurogenesis, Dev. Dyn., 208, 92, 10.1002/(SICI)1097-0177(199701)208:1<92::AID-AJA9>3.0.CO;2-X Lyden, 1999, Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts, Nature, 401, 670, 10.1038/44334 Barone, 1994, Id proteins control growth induction in mammalian cells, Proc. Natl. Acad. Sci. U. S. A., 91, 4985, 10.1073/pnas.91.11.4985 Moldes, 1997, Id3 prevents differentiation of preadipose cells, Mol. Cell. Biol., 17, 1796, 10.1128/MCB.17.4.1796 Herrera-Herrera, 2008, RFamide neuropeptides inhibit murine and human adipose differentiation, Biochem. Biophys. Res. Commun., 377, 29, 10.1016/j.bbrc.2008.09.071 Cutchins, 2012, Inhibitor of differentiation-3 mediates high fat diet-induced visceral fat expansion, Arterioscler. Thromb. Vasc. Biol., 32, 317, 10.1161/ATVBAHA.111.234856 Doran, 2008, The helix–loop–helix factors Id3 and E47 are novel regulators of adiponectin, Circ. Res., 103, 624, 10.1161/CIRCRESAHA.108.175893 Lim, 2005, Molecular mechanisms regulating expression and function of transcription regulator inhibitor of differentiation 3, Acta Pharmacol. Sin., 26, 1409, 10.1111/j.1745-7254.2005.00207.x Benezra, 2001, The Id proteins and angiogenesis, Oncogene, 20, 8334, 10.1038/sj.onc.1205160 Lyden, 2001, Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth, Nat. Med., 7, 1194, 10.1038/nm1101-1194 Lasorella, 2001, Id proteins at the cross-road of development and cancer, Oncogene, 20, 8326, 10.1038/sj.onc.1205093 Valdimarsdottir, 2002, Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells, Circulation, 106, 2263, 10.1161/01.CIR.0000033830.36431.46 Sakurai, 2004, Crucial role of inhibitor of DNA binding/differentiation in the vascular endothelial growth factor-induced activation and angiogenic processes of human endothelial cells, J. Immunol., 173, 5801, 10.4049/jimmunol.173.9.5801 Forrest, 2004, Intron retention generates a novel Id3 isoform that inhibits vascular lesion formation, J. Biol. Chem., 279, 32897, 10.1074/jbc.M404882200 Forrest, 2004, Phosphorylation regulates Id3 function in vascular smooth muscle cells, Circ. Res., 95, 557, 10.1161/01.RES.0000142735.67542.5a Tsuchiya, 2005, Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer, Cancer Sci., 96, 784, 10.1111/j.1349-7006.2005.00113.x Deed, 1996, Attenuated function of a variant form of the helix–loop–helix protein, Id-3, generated by an alternative splicing mechanism, FEBS Lett., 393, 113, 10.1016/0014-5793(96)00868-X Matsumura, 2001, Vascular injury induces posttranscriptional regulation of the Id3 gene: cloning of a novel Id3 isoform expressed during vascular lesion formation in rat and human atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 21, 752, 10.1161/01.ATV.21.5.752 Arita, 1999, Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity, Biochem. Biophys. Res. Commun., 257, 79, 10.1006/bbrc.1999.0255 Carlson, 2009, Pre- and post-prandial appetite hormone levels in normal weight and severely obese women, Nutr. Metab., 6, 32, 10.1186/1743-7075-6-32 Steinberg, 2007, Adiponectin: starving for attention, Cell Metab., 6, 3, 10.1016/j.cmet.2007.06.008 Scherer, 2006, Adipose tissue: from lipid storage compartment to endocrine organ, Diabetes, 55, 1537, 10.2337/db06-0263 Moldes, 1999, Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) trans-factors for the regulation of fatty acid synthase promoter in adipocytes, Biochem. J., 344, 873, 10.1042/bj3440873 Scioli, 2014, The biomolecular basis of adipogenic differentiation of adipose-derived stem cells, Int. J. Mol. Sci., 15, 6517, 10.3390/ijms15046517 Ye, 2011, Regulation of stem cell differentiation in adipose tissue by chronic inflammation, Clin. Exp. Pharmacol. Physiol., 38, 872, 10.1111/j.1440-1681.2011.05596.x Nishimura, 2007, Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels, Diabetes, 56, 1517, 10.2337/db06-1749 Peinado, 2010, The stromal-vascular fraction of adipose tissue contributes to major differences between subcutaneous and visceral fat depots, Proteomics, 10, 3356, 10.1002/pmic.201000350 Zeyda, 2007, Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production, Int. J. Obes., 31, 1420, 10.1038/sj.ijo.0803632 Welch, 2001, Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model, Proc. Natl. Acad. Sci. U. S. A., 98, 7946, 10.1073/pnas.141239098 Wang, 2004, Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis, Am. J. Hum. Genet., 74, 262, 10.1086/381560 Doran, 2010, Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima–media thickness in humans, Circ. Res., 106, 1303, 10.1161/CIRCRESAHA.109.210294 Manichaikul, 2014, A functionally significant polymorphism in ID3 is associated with human coronary pathology, PLoS One, 9, e90222, 10.1371/journal.pone.0090222 Rupnick, 2002, Adipose tissue mass can be regulated through the vasculature, Proc. Natl. Acad. Sci. U. S. A., 99, 10730, 10.1073/pnas.162349799 Brakenhielm, 2004, Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice, Circ. Res., 94, 1579, 10.1161/01.RES.0000132745.76882.70 Cao, 2007, Angiogenesis modulates adipogenesis and obesity, J. Clin. Invest., 117, 2362, 10.1172/JCI32239 Cao, 2010, Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases, Nat. Rev. Drug Discov., 9, 107, 10.1038/nrd3055 Doran, 2012, B-cell aortic homing and atheroprotection depend on Id3, Circ. Res., 110, e1, 10.1161/CIRCRESAHA.111.256438 Lipinski, 2012, Loss of Id3 increases VCAM-1 expression, macrophage accumulation, and atherogenesis in Ldlr−/− mice, Arterioscler. Thromb. Vasc. Biol., 32, 2855, 10.1161/ATVBAHA.112.300352 Perry, 2013, Helix–loop–helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation, Arterioscler. Thromb. Vasc. Biol., 33, 2771, 10.1161/ATVBAHA.113.302571 Holm, 2009, Atherosclerotic plaque development and instability: a dual role for VEGF, Ann. Med., 41, 257, 10.1080/07853890802516507 Sun, 2011, Adipose tissue remodeling and obesity, J. Clin. Invest., 121, 2094, 10.1172/JCI45887 Sun, 2012, Dichotomous effects of VEGF-A on adipose tissue dysfunction, Proc. Natl. Acad. Sci. U. S. A., 109, 5874, 10.1073/pnas.1200447109 Tam, 2009, Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells, PLoS One, 4, e4974, 10.1371/journal.pone.0004974 Miyazawa-Hoshimoto, 2003, Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects, Diabetologia, 46, 1483, 10.1007/s00125-003-1221-6 Pang, 2008, Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity, Am. J. Physiol. Endocrinol. Metab., 295, E313, 10.1152/ajpendo.90296.2008 Ye, 2007, Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice, Am. J. Physiol. Endocrinol. Metab., 293, E1118, 10.1152/ajpendo.00435.2007 Wice, 2001, Glucose and other insulin secretagogues induce, rather than inhibit, expression of Id-1 and Id-3 in pancreatic islet beta cells, Diabetologia, 44, 453, 10.1007/s001250051643